Location History:
- Rieurserorf, DE (1999)
- Millienhagen, DE (2002 - 2006)
- Millienhage, DE (2008)
Company Filing History:
5 out of 1,248 
2 out of 1,942 
1 out of 104 
Years Active: 1999-2008
Title: The Innovations of Egbert Mundt
Introduction
Egbert Mundt is a notable inventor based in Millienhagen, Germany. He has made significant contributions to the field of virology, particularly in the development of vaccines and viral mutants. With a total of eight patents to his name, Mundt's work has had a considerable impact on the scientific community.
Latest Patents
Mundt's latest patents include an invention related to the infectious bursal disease virus (IBDV). This mutant expresses virus neutralizing epitopes specific for both classic and variant IBDV strains. The invention provides a classic IBDV mutant that additionally comprises virus neutralizing epitopes specific for variant-E IBDV. Another significant patent is for a recombinant birnavirus vaccine. This invention provides a birnavirus mutant that is suited as a vaccine candidate in eradication control programs. The mutant is designed not to produce a native VP5 protein, which can be used as a marker to distinguish between animals vaccinated with the VP5 mutant and those infected with a naturally occurring birnavirus.
Career Highlights
Throughout his career, Mundt has worked with prominent organizations such as Akzo Nobel N.V. and the University System of Maryland. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mundt has collaborated with notable colleagues, including Adriaan Antonius Wilhelmus Maria Van Loon and Vikram N Vakharia. These partnerships have further enhanced his research and innovation in virology.
Conclusion
Egbert Mundt's contributions to the field of virology through his patents and collaborations highlight his importance as an inventor. His work continues to influence vaccine development and disease control strategies.